Adenosine

Adenosine

SCHEMBL3014288

CSCCC(N)C(=O)O.Nc1ncnc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O

nearest known ligand 0.77

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADORA1ADORA2AADORA2BADORA3

The experimentally established mechanism targets of Adenosine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA3 known ✓ P0DMS8 1/20 0.70
ADORA2A known ✓ P29274 1/20 0.70
ADORA2B known ✓ P29275 1/20 0.70
ADORA1 known ✓ P30542 1/20 0.70
MARS1 P56192 3/20 0.77
DOT1L Q8TEK3 6/20 0.76
CARM1 Q86X55 5/20 0.76
NSD2 O96028 4/20 0.76
SETD7 Q8WTS6 4/20 0.76
EHMT2 Q96KQ7 3/20 0.76
NNMT P40261 3/20 0.76
PRMT1 Q99873 3/20 0.76
FASN P49327 3/20 0.76
TRDMT1 O14717 2/20 0.76
PRMT5 O14744 2/20 0.76
INMT O95050 2/20 0.76
METTL3 Q86U44 2/20 0.76
EHMT1 Q9H9B1 2/20 0.76
METTL14 Q9HCE5 2/20 0.76
KMT2A Q03164 2/20 0.76

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Adenosine SCHEMBL27500408 1.00 MARS1 (0.77) MARS1DOT1LCARM1NSD2SETD7
Adenosine SCHEMBL3014297 1.00 MARS1 (0.77) MARS1DOT1LCARM1NSD2SETD7
Adenosine SCHEMBL27683410 0.99 MARS1 (0.75) MARS1DOT1LCARM1NSD2SETD7
Adenosine SCHEMBL28733069 0.97 MARS1 (0.72) MARS1DOT1LCARM1NSD2SETD7
Adenosine SCHEMBL28535357 0.97 MARS1 (0.72) MARS1DOT1LCARM1NSD2SETD7
Adenosine SCHEMBL28544361 0.97 MARS1 (0.72) MARS1DOT1LCARM1NSD2SETD7
Adenosine SCHEMBL29735027 0.93 MARS1 (0.74) MARS1DOT1LCARM1NSD2SETD7
Adenosine SCHEMBL25303131 0.93 MARS1 (0.67) MARS1DOT1LCARM1NSD2SETD7
Racemethionine SCHEMBL28493813 0.92 MARS1 (0.75) MARS1DOT1LCARM1NSD2SETD7
Adenosine SCHEMBL20490833 0.91 MARS1 (0.65) MARS1DOT1LCARM1NSD2SETD7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 104 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109563375-A Tungsten barrier polishing slurry composition 凯斯科技股份有限公司 2019-04-02 CN claimed
CN-105567786-B A kind of thiopurine methyltransferase enzyme activity detection kit 北京中科唯新生物医学研究所有限公司 2019-01-25 CN claimed
CN-105445464-B A kind of methionine adenosyltransferase Determination of biological activity method and kit 湖南天合生物技术有限公司 2017-12-01 CN claimed
CN-104178540-A Method for synthesizing ademetionine by biological catalytic process ZHEJIANG ZHENYUAN PHARMACEUTICAL CO LTD 2014-12-03 CN claimed
CN-101392230-B Recombinant escherichia coli for expressing adenosylmethionine synthetase BEIJING KAWIN TECHNOLOGY CO LTD 2012-05-23 CN claimed
CN-102458497-A Catheter balloon coated with shellac and paclitaxel EUROCOR GMBH 2012-05-16 CN claimed
CN-1955306-B Method of saccharomycetes bio-synthesing, of producing optical pure adenosine methionine and its culture solution SHANGHAI INST PHARM INDUSTRY 2011-03-16 CN claimed
CN-101392230-A Recombinant escherichia coli for expression of adenomethionine synthetase BEIJING KAWIN TECHNOLOGY CO LT (CN) 2009-03-25 CN claimed
CN-100465282-C Method for synthesizing adenosine methionine utilizing biological catalysis JILIN QIJIAN BIOLOG TECHNOLOGY (CN) 2009-03-04 CN claimed
CN-1955306-A Method of saccharomycetes bio-synthesing, producing optical pure adenosine methionine and its culture solution SHANGHAI MEDICIAL INDUSTRY INS (CN) 2007-05-02 CN claimed
CN-1814774-A Method for synthesizing adenosine methionine utilizing biological catalysis QIJIAN BIOLOG TECHNOLOGY CO LT (CN) 2006-08-09 CN claimed
CN-1665554-A Compounds and method for coating surfaces in a haemocompatible manner HEMOTEQ GMBH (DE) 2005-09-07 CN claimed
WO-2024100025-A1 IMPROVED VACCINE ONCODNA (BE) 2024-05-16 WO disclosed
EP-4364752-A1 IMPROVED VACCINE OncoDNA (BE) 2024-05-08 EP disclosed
WO-2023169554-A8 METHIONINE ADENOSYLTRANSFERASE INHIBITOR, PREPARATION METHOD THEREFOR AND USE THEREOF 赛诺哈勃药业(成都)有限公司 2023-11-09 WO disclosed
WO-2023169554-A1 METHIONINE ADENOSINE TRANSFERASE INHIBITOR, PREPARATION METHOD THEREFOR AND USE THEREOF 赛诺哈勃药业(成都)有限公司 2023-09-14 WO disclosed
CN-1814774-A Method for synthesizing adenosine methionine utilizing biological catalysis QIJIAN BIOLOG TECHNOLOGY CO LT (CN) 2006-08-09 CN disclosed
CN-1814774-A Method for synthesizing adenosine methionine utilizing biological catalysis QIJIAN BIOLOG TECHNOLOGY CO LT (CN) 2006-08-09 CN disclosed
CN-1814774-A Method for synthesizing adenosine methionine utilizing biological catalysis QIJIAN BIOLOG TECHNOLOGY CO LT (CN) 2006-08-09 CN disclosed
CN-1182367-A Novel use of -adenosyl-L-methionine (SAMe) KNOLL AG (DE) 1998-05-20 CN disclosed